FDA Suggests CGMP Compliance Alternatives for Combination Products

International Pharmaceutical Regulatory Monitor
A A
The FDA released a list of alternative suggestions for complying with CGMP requirements for drug combination products that covers stability testing, release for distribution, reserve samples and special testing requirements.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor